Redefining neuroscience drug development.
Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharmaceutical company founded in 2021 to confront the global brain disease crisis through precision medicine. The company develops novel therapies targeting unproven mechanisms of action for neuropsychiatric and neurodegenerative disorders, pairing each drug candidate with a biomarker strategy to identify the right patients. Its pipeline includes treatments for depression, Alzheimer's agitation, and other CNS diseases.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountSep 2023
Oct 2022
Oct 2021
Create a free account to see which investors have funded this company.
Create Free Account
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
